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~ The Exercise Echocardlogmphlc Profile o f  
Healthy Post Menopausal Women 
vi|w K. Gulati. James M. Hagberg, Steve D. McCole, John Gorcsan Ill. 
University of Pittsburgh, Pittsburgh, PA 
The dynamic ardiac response to uptight exercise has not been well charac- 
terized in healthy post-manopausal women. Accordingly, 20 such volunteers, 
aged 64 + 6 yrs, undenNant cedal echocardiograpific study of LV volumes 
by modified Stmpson's rule at rest and during each stage of updght bicycle 
exercise. Work rate was increased by 15 W every 3 rain until exhaustion. 
Peak work rate ranged from 45 to 105 W. As expected, progressive increases 
in cardiac output (CO) eccurmd with exercise. Sevsnty-six % of this increase 
was at~)uted to increases in heart rate and 24% to increases in s~rcke 
v(dume (SV), p < 0,05, rest vs. 30 W and 30 vs. 90 W). Augmentation in 
SV was assecla~d with significant progressive increases in end,diast01ic 
volume (13 < 0.05, rest vs. 46 W and 45 vs. 90 W) as end-systolic volume 
was unchanged. LV ejection fraction rose slightly from group mean of 67% 
et rest to 75% at 105 W (p < 0.01). 
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Conclusions: The cardiac response to upright exercise in healthy post- 
menopausal women may be charactedzed by progressive increases in end- 
diastolic volume, heart rate, SVo CO, and ejection fraction. These data may 
be clinically useful to identify an abnormal cardiac exercise response in 
post-menopausal lots with heart disease. 
~ Exercise for the Evaluation of  Testing 
Lipid-Lowering Therapy. Functional Assessment 
Versus Quantitative Coronary Angiography in the 
Low-Density-Lipoprctein Aphemsts 
Atherosclerosis Regression Study 
W1m R. Aangevaeran, Abraham A. Krcon, "l'jeerd van der Werf, Gerard 
J, Uijen, Anton R StalanhoeL Departments orC, ardioto~yand General 
Internal Medicine, University Hospital Nijrnegen, The Netherlands 
In patients with coronary artery disease (CAD) exercise testing is used for 
evaluation of PTCA, CABG and anti-anginal drug therapy. Little information 
is available about the potential of exercise testing for the evaluation of lipid- 
icwedng therapy. 
Method: We studied 42 patients with familial hypercholasterelemia and 
extensive CAD who were randomized to diet and simvastatin with or without 
biweekly LDL-apheresls. LDL-aphemsls was performed over dext~n sul- 
phate columns. Blciycie exercise tasting was performed under standardized 
conditions at baseline (base), after 1 and 2 years of therapy. The tinal exercise 
test was performed 1 month after the last LDL-apherasie to ~void possible 
short term effects on blood rhcolagy. Mean segment diameter (MSD) and 
minimal obstruction diameter (MOD) were assessed by QCA. 
Results: LDL-chalesterel decreased from 7.72 ± 1.38 mmol/i to a time 
averaged level of 2.95 4- 1.13 (-63%) in the LDL-apheresls {L) group end 
from 7.85 4- 2.34 mmol/I to 4.13:1:1.58 mmci/1 (-43%) in the medication (M) 
group, dilference in response p < 0.01. 
Exercise LOL-epheresls Medication 
testing base 1 year 2 years base 1 year 2 years 
ST-time(s) 4614-47 548:1:51 6414-50 • 48Sd:81 464~54 442±60 
ST-max(mm) 1.4:1:0.2 0.84-0.2 0.7:1:0.2" 1.44-0.3 1.3:k0.4 1.4~0.4 
ST-time, time to 1 mm (= 0.1 mV) ST-depression; ST.max, maximal ST depression; 
• dllference between L and M group p < 0.01. (}CA revealed no difference incoronary 
anatomy. 
Conclusions: Exercise parameters improved only in the LOL-apherecls 
group along with a pronouced reduction {n LDL-cholesterel but without 
change in coronary anatomy. Exercise testing, a functional test of the coro- 
nary circulation, has to be considered as a valuable inexpensive tool for the 
evaluation of lipid-lowedng therapy in patients with myocardial ischemia. 
~ Elevsted Intramuscular Diprotonsted (H2PO4") Pi 
OurMg Exercise In Patients With Chronic Heart 
Failure 
Michael Welsch, Heldi Kfuess, William Brechue, Ray Ballinger, 
Kethedne Scott, M/chael Policc~ Cad J. Peplne. D/v. of Cardiovascular 
Meal., Centor for Exercise Science., Univ. or Florida and the VAMC, 
Gainesville, FL 
We have shown thet metabolic downreguletion may depress muscle function 
in chronic heart failure (HF). This study examined muscle energetius in 10 
HF pts (age: 58 ~ 5 yrs, EF < 40% ~ 10, NYHA II-)it) and 10 controls 
(CON) (age: 62 4- 4 yrs) during low (LO; 25% MVC) and high (HI; 85% MVC) 
Intensity cell flexion exe~se (1 contract/4 el. From an RF coil positioned 
over the medial gas~oc head continuous pectra were collected (32 s t~me 
resolution), LO wa,; terminated at 10 rain and resulted in a decrease in [PCr] 
(HF: 38.75 ~ 0.76 to 20.46 4-1.95 raM, CON: 38,01 ± 0.73 to 27.75 -;-.2.74 
raM} and pH (HF: 7.09:1:0.04 to 6.91 ± 0.05, CON: 7.05:1:0.05 to 7.04 
0.08), and an increase in [Pq (HF: 5.51 :~ 0.57 to 16.12 ~ 1.47 raM, CON: 
5.15 ± 0.46 to 13A1 ÷_ 1.67 mM). HI was terminated at exhaustion (HF: 4:00, 
CON: 4:25) resulting i~ greater changes in [PCr] (HF: 37.78 ± 1.04 to 12.79 
~: 2.64 raM, CON: 38.43 ± 0.78 to 12.89 ± 1.58 raM) and pH (HF: 7.11:1: 
0.10 to 6.65 :k 0.19, CON:7.09 4- 0,02 to 6.90 -4- 0,08), and an increase tn [Pi] 
(HF: 4.96 ± 0.41 to 20.42 ± 1.95 raM, CON: 4,99 4- 0.62 to 19.61 ~ 1.06 raM) 
compared to LI. [ATP] remained unchanged dudng both conditions. Exercise 
was associated with a greater decline in pH (LO&HI) and increase in [Pi] 
(LO) in HI:. This res~Jlted in more H2PO; in HF compared to CON (LO:HF: 
275% ~ 51, CON: 101% ± 20; HhHF: 740% + 192, CON: 441% ± 43) (p < 
0.05). This increase in H~PO~ may be associated with reduced contrac~ia 
function by altedng cross-bd~ge kinetics and may contribute to the marked 
exercise limitations in HR 
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~ Apoptosls of Human Endothelial Cells Is Induced 
Synergistically by Ox-LDL and TNFoq Attenuation 
by 17~-Estradiol 
Rend J. Aivamz Jr., Arthur T. Hoang, Emily E. Miifiken, SanfJrd J. Gipa, Chi. 
V. Dang, Pascal J. Goldschmldt-Ctermont. Johns Hopkins Hospital, 
Baltimore, MD 
Endothelial cell (EC) dysfunction, increased cell turnover and apoptosis have 
been implicated in the promotion and progression of atheroscleresis. Estro- 
gen rnetabolites have been shown to be potent anti-etheroganio agents, 
although the mechanism of protection has not been completely defined. 
In other systems, TNF= and ox|dized-LDL (ox-LDL) have been shown to be 
strong inducers of apoptosis. We have evidence that the estrogen metabolite, 
17/bestradiol (EST), reduces EC apopte~is induced by ox-LDL and TNF=. 
We sought to further charastedze the effect of 17.8-estradiol n EC apoptosls. 
Human EC were cultured in the presence or absence of varying concen- 
trations of non-oxidized LDL (LDL) and ox-LDL with or without 50 mg/L of 
TNF~. Morphology of the cells was studied by phase microscopy and apopto- 
sis was determined by FACS analysis of dlgoxigenin-laballed genomlo DNA 
fragments (TUNEL assay). 
TNFa (50 rag/L) and ox-LDL (50 rag/L) in combination lead to morphologic 
changes consistent with apoptoeis: retraction of the EC cells, loss of adhesion 
to the substratum, and membrane blabbing. When cells were analyzed after 
72 hrs by TUNEL, TNFa (50 rng/L) and ox-I_OL (50 m q/L~ alone lead to 
apoptosis of EC in 15% and 14% of cells, respectively. Hog, aver, co-culture 
of EC with ox-LDL (50 mg/L) and TNFa (50 rag/L) resulted in apoptosis 
of 55% of the EC. The apoptesis induced by the combination of 50 n~/L 
ox-LOL and 50 mg/L TNFa was attenuated by 39% with pro-treatment of the 
ceils with 10 -s M 17#-estradioL LDL did not induce apoptesls of EC in the 
presence or absence of TNF=. 
Thus, we conclude that TNFa and ox-LDL seem to act synergistically to 
induce apoptosls in EG. The process of apoptosis is attenuated by 17,8- 
estradlol and may account for some of the anti-etheragenlc properties of 
estrogens. 
